PMID: 9544646Apr 17, 1998Paper

Additional procedures after the initial vitrectomy or tap-biopsy in the Endophthalmitis Vitrectomy Study

Ophthalmology
B H DoftS R Wisniewski

Abstract

The study aimed to assess the frequency, indications, and outcome of additional ocular procedures after initial treatment of vitrectomy (VIT) or tap-biopsy (TAP) for patients with endophthalmitis after cataract extraction. The study design was an analysis of observational data collected as part of a multicenter, randomized clinical trial. Of the 420 patients enrolled in the Endophthalmitis Vitrectomy Study, the 148 who had additional procedures were compared with the 272 who did not. The types, indications, and number of additional ocular procedures were assessed. A masked examiner measured visual acuity 9 to 12 months after study entry. Within 1 week of study entry, 8% of VIT eyes and 13% of TAP eyes underwent additional procedures, 14% for complications of the initial procedure and 86% for worsening ocular inflammation or infection. Cultures were obtained in 33 of the 38 eyes operated on for worsening inflammation or infection and were positive in 42%. Cultures obtained from the early additional procedures were positive more frequently in eyes with an initial TAP (71%) than in eyes with an initial VIT (13%). Both virulence of initial microbiologic organism isolated and poor presenting vision were risk factors for requirement ...Continue Reading

References

Mar 1, 1995·Ophthalmology·A ShaarawyH E Ibanez

❮ Previous
Next ❯

Citations

Jun 24, 2009·Current Infectious Disease Reports·Marlene L Durand
Dec 23, 1998·Survey of Ophthalmology·M S KresloffM A Zarbin
Jun 16, 2001·Journal of Cataract and Refractive Surgery·H J KohO W Kwon
Jun 5, 2003·Journal of Cataract and Refractive Surgery·Süleyman KaynakGüray Cingil
Dec 4, 2004·International Ophthalmology Clinics·Harry W FlynnDennis P Han
Dec 12, 2002·Retina·Destry J SulkesWilliam J Feuer
Oct 20, 2004·Retina·Rama D JagerEmmett T Cunningham
Jul 11, 2007·Retina·Craig A Lemley, Dennis P Han
Sep 7, 2000·Journal of Clinical Pharmacology·P B WilliamsP V Mitrev
Jan 31, 2012·International Journal of Inflammation·David J JacobsWei Shi
Jan 1, 2011·ISRN Ophthalmology·Jin A Choi, Sung Kun Chung
Jul 1, 2012·Asia-Pacific Journal of Ophthalmology·Manish NagpalKamal Nagpal
Jan 1, 2012·Asia-Pacific Journal of Ophthalmology·Avinash PathengayHarry W Flynn
Jul 26, 2011·Journal of Cataract and Refractive Surgery·Mark PackerUNKNOWN ASCRS Cataract Clinical Committee
Mar 15, 2011·Survey of Ophthalmology·Neelakshi BhagatMarco Zarbin
Feb 28, 2016·American Journal of Ophthalmology·Ella H LeungLaura C Huang
Oct 16, 2014·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Søren Solborg BjerrumMorten La Cour
Mar 31, 2017·Clinical Microbiology Reviews·Marlene L Durand
Jan 8, 2020·Ocular Immunology and Inflammation·Chang Sup LeeYevgeniy Eugene Shildkrot
Jan 10, 2001·Current Opinion in Ophthalmology·P Montan
Jan 25, 2002·Current Opinion in Ophthalmology·Nick MamalisEric Brinton
Oct 23, 2019·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Marcel KitscheNaim Terai
Oct 30, 2004·Seminars in Ophthalmology·Taraprasad DasUNKNOWN Hyderabad Endophthalmitis Research Group
Feb 11, 2021·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·L MautoneM S Spitzer
Sep 11, 2021·Ophthalmic Surgery, Lasers & Imaging Retina·Xiaofan MiXihui Lin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.